142 related articles for article (PubMed ID: 17463087)
1. Cell proliferation and survival induced by Toll-like receptors is antagonized by type I IFNs.
Hasan UA; Caux C; Perrot I; Doffin AC; Menetrier-Caux C; Trinchieri G; Tommasino M; Vlach J
Proc Natl Acad Sci U S A; 2007 May; 104(19):8047-52. PubMed ID: 17463087
[TBL] [Abstract][Full Text] [Related]
2. Selenium suppresses the activation of transcription factor NF-kappa B and IRF3 induced by TLR3 or TLR4 agonists.
Youn HS; Lim HJ; Choi YJ; Lee JY; Lee MY; Ryu JH
Int Immunopharmacol; 2008 Mar; 8(3):495-501. PubMed ID: 18279804
[TBL] [Abstract][Full Text] [Related]
3. TLR3 signaling in a hepatoma cell line is skewed towards apoptosis.
Khvalevsky E; Rivkin L; Rachmilewitz J; Galun E; Giladi H
J Cell Biochem; 2007 Apr; 100(5):1301-12. PubMed ID: 17243100
[TBL] [Abstract][Full Text] [Related]
4. Modification of TLR-induced activation of human dendritic cells by type I IFN: synergistic interaction with TLR4 but not TLR3 agonists.
Walker J; Tough DF
Eur J Immunol; 2006 Jul; 36(7):1827-36. PubMed ID: 16783851
[TBL] [Abstract][Full Text] [Related]
5. TNF receptor-associated factor-1 (TRAF1) negatively regulates Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF)-mediated signaling.
Su X; Li S; Meng M; Qian W; Xie W; Chen D; Zhai Z; Shu HB
Eur J Immunol; 2006 Jan; 36(1):199-206. PubMed ID: 16323247
[TBL] [Abstract][Full Text] [Related]
6. Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells.
Mäkelä SM; Strengell M; Pietilä TE; Osterlund P; Julkunen I
J Leukoc Biol; 2009 Apr; 85(4):664-72. PubMed ID: 19164128
[TBL] [Abstract][Full Text] [Related]
7. TLR3 ligand induces NF-{kappa}B activation and various fates of multiple myeloma cells depending on IFN-{alpha} production.
Chiron D; Pellat-Deceunynck C; Amiot M; Bataille R; Jego G
J Immunol; 2009 Apr; 182(7):4471-8. PubMed ID: 19299748
[TBL] [Abstract][Full Text] [Related]
8. Synergism of Toll-like receptor-induced interleukin-12p70 secretion by monocyte-derived dendritic cells is mediated through p38 MAPK and lowers the threshold of T-helper cell type 1 responses.
Bohnenkamp HR; Papazisis KT; Burchell JM; Taylor-Papadimitriou J
Cell Immunol; 2007 Jun; 247(2):72-84. PubMed ID: 17927969
[TBL] [Abstract][Full Text] [Related]
9. Soluble G protein of respiratory syncytial virus inhibits Toll-like receptor 3/4-mediated IFN-beta induction.
Shingai M; Azuma M; Ebihara T; Sasai M; Funami K; Ayata M; Ogura H; Tsutsumi H; Matsumoto M; Seya T
Int Immunol; 2008 Sep; 20(9):1169-80. PubMed ID: 18611945
[TBL] [Abstract][Full Text] [Related]
10. Guggulsterone suppresses the activation of transcription factor IRF3 induced by TLR3 or TLR4 agonists.
Youn HS; Ahn SI; Lee BY
Int Immunopharmacol; 2009 Jan; 9(1):108-12. PubMed ID: 19000789
[TBL] [Abstract][Full Text] [Related]
11. Bacterial lipopolysaccharide induces increased expression of toll-like receptor (TLR) 4 and downstream TLR signaling molecules in bovine mammary epithelial cells.
Ibeagha-Awemu EM; Lee JW; Ibeagha AE; Bannerman DD; Paape MJ; Zhao X
Vet Res; 2008; 39(2):11. PubMed ID: 18096120
[TBL] [Abstract][Full Text] [Related]
12. Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists.
Figueiredo MD; Vandenplas ML; Hurley DJ; Moore JN
Vet Immunol Immunopathol; 2009 Jan; 127(1-2):125-34. PubMed ID: 19019456
[TBL] [Abstract][Full Text] [Related]
13. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.
Miyazaki M; Kanto T; Inoue M; Itose I; Miyatake H; Sakakibara M; Yakushijin T; Kakita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
J Med Virol; 2008 Jun; 80(6):980-8. PubMed ID: 18428149
[TBL] [Abstract][Full Text] [Related]
14. The cytoplasmic 'linker region' in Toll-like receptor 3 controls receptor localization and signaling.
Funami K; Matsumoto M; Oshiumi H; Akazawa T; Yamamoto A; Seya T
Int Immunol; 2004 Aug; 16(8):1143-54. PubMed ID: 15226270
[TBL] [Abstract][Full Text] [Related]
15. Suppression of the TRIF-dependent signaling pathway of Toll-like receptors by luteolin.
Lee JK; Kim SY; Kim YS; Lee WH; Hwang DH; Lee JY
Biochem Pharmacol; 2009 Apr; 77(8):1391-400. PubMed ID: 19426678
[TBL] [Abstract][Full Text] [Related]
16. Double-stranded RNA induces pancreatic beta-cell apoptosis by activation of the toll-like receptor 3 and interferon regulatory factor 3 pathways.
Dogusan Z; García M; Flamez D; Alexopoulou L; Goldman M; Gysemans C; Mathieu C; Libert C; Eizirik DL; Rasschaert J
Diabetes; 2008 May; 57(5):1236-45. PubMed ID: 18223009
[TBL] [Abstract][Full Text] [Related]
17. Poly I:C-induced activation of NK cells by CD8 alpha+ dendritic cells via the IPS-1 and TRIF-dependent pathways.
Miyake T; Kumagai Y; Kato H; Guo Z; Matsushita K; Satoh T; Kawagoe T; Kumar H; Jang MH; Kawai T; Tani T; Takeuchi O; Akira S
J Immunol; 2009 Aug; 183(4):2522-8. PubMed ID: 19635904
[TBL] [Abstract][Full Text] [Related]
18. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling.
Liotta F; Angeli R; Cosmi L; Filì L; Manuelli C; Frosali F; Mazzinghi B; Maggi L; Pasini A; Lisi V; Santarlasci V; Consoloni L; Angelotti ML; Romagnani P; Parronchi P; Krampera M; Maggi E; Romagnani S; Annunziato F
Stem Cells; 2008 Jan; 26(1):279-89. PubMed ID: 17962701
[TBL] [Abstract][Full Text] [Related]
20. Phosphatase PTP1B negatively regulates MyD88- and TRIF-dependent proinflammatory cytokine and type I interferon production in TLR-triggered macrophages.
Xu H; An H; Hou J; Han C; Wang P; Yu Y; Cao X
Mol Immunol; 2008 Aug; 45(13):3545-52. PubMed ID: 18571728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
